INSERM (Institut National de la Sante et de la Recherche Medicale);DBV Technologies
发明人:
Lacroix-Desmazes, Sebastien,Mondoulet, Lucie,Dioszeghy, Vincent
申请号：
AU2014339034
公开号：
AU2014339034A1
申请日:
2014.10.21
申请国别(地区):
AU
年份:
2016
代理人:
摘要：
The present invention relates to the treatment of haemophilia. More specifically, the invention relates to a new method of inducing an immune tolerance against at least one blood factor used to treat haemophilia through the epicutaneous route by application of a skin patch device comprising a blood factor in order to continue haemophilia treatment. The present invention also relates to the skin patch device containing Factor VIII.
